Di seguito sono riportati alcuni degli articoli scientifici originali pubblicati dal dr. Umberto Capitanio sulle piu' prestigiose riviste scientifiche in campo urologico ed uro-oncologico:

Capitanio U, Montorsi F. Renal cancer. Lancet. 2015 Aug 25. pii: S0140-6736(15)00046-X. doi: 10.1016/S0140-6736(15)00046-X. [Epub ahead of print] Review. PubMed PMID: 26318520.

Capitanio U, Volpe A. Renal Tumor Biopsy: More Dogma Belied. Eur Urol. 2015 May 21. pii: S0302-2838(15)00408-X. doi: 10.1016/j.eururo.2015.05.007. [Epub ahead of print] PubMed PMID: 26004797.

Capitanio U, Briganti A. Words of wisdom. Re: Surgical outcomes in the management of isolated nodal recurrences: a multicenter, international retrospective cohort. Eur Urol. 2015 May;67(5):974-5. doi: 10.1016/j.eururo.2014.12.064. PubMed PMID: 25845960.

Capitanio U, Terrone C, Antonelli A, Minervini A, Volpe A, Furlan M, Matloob R, Regis F, Fiori C, Porpiglia F, Di Trapani E, Zacchero M, Serni S, Salonia A, Carini M, Simeone C, Montorsi F, Bertini R. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function. Eur Urol. 2015 Apr;67(4):683-9. doi: 10.1016/j.eururo.2014.09.027. Epub 2014 Oct 3. PubMed PMID: 25282367.

Capitanio U, Suardi N, Matloob R, Roscigno M, Abdollah F, Di Trapani E, Moschini M, Gallina A, Salonia A, Briganti A, Montorsi F, Bertini R. Extent of lymph node dissection at nephrectomy affects cancer-specific survival and metastatic progression in specific sub-categories of patients with renal cell carcinoma (RCC). BJU Int. 2014 Aug;114(2):210-5. doi: 10.1111/bju.12508. Epub 2014 May 22. PubMed PMID: 24854206.

Capitanio U, Abdollah F, Matloob R, Salonia A, Suardi N, Briganti A, Carenzi C, Rigatti P, Montorsi F, Bertini R. Effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: Implications for multimodal therapy. Int J Urol. 2012 Nov 19. doi:10.1111/iju.12004. [Epub ahead of print] PubMed PMID: 23163758. 

Capitanio U, Suardi N, Matloob R, Abdollah F, Castiglione F, Briganti A, Carenzi C, Roscigno M, Montorsi F, Bertini R. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis. BJU Int. 2012 Jun  15. doi: 10.1111/j.1464-410X.2012.11313.x. [Epub ahead of print] PubMed PMID: 22703190.

Capitanio U, Matloob R, Suardi N, Abdollah F, Castiglione F, Di Trapani D, Russo A, Briganti A, Carenzi C, Salonia A, Montorsi F, Rigatti P, Bertini R. The  extent of lymphadenectomy does affect cancer specific survival in pathologically confirmed T4 renal cell carcinoma. Urologia. 2012 Apr-Jun;79(2):109-15. doi:10.5301/RU.2012.9255. PubMed PMID: 22610843.

Capitanio U, Becker F, Blute ML, Mulders P, Patard JJ, Russo P, Studer UE, Van Poppel H. Lymph node dissection in renal cell carcinoma. Eur Urol. 2011 Dec;60(6):1212-20. doi: 10.1016/j.eururo.2011.09.003. Epub 2011 Sep 13. Review. PubMed PMID: 21940096.

Capitanio U, Suardi N, Briganti A, Gallina A, Abdollah F, Lughezzani G, Salonia A, Freschi M, Montorsi F. Influence of obesity on tumour volume in patients with prostate cancer. BJU Int. 2012 Mar;109(5):678-84. doi: 10.1111/j.1464-410X.2011.10453.x. Epub 2011 Jul 20. PubMed PMID: 21777363.

Capitanio U, Montorsi F. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol. 2011 Jun;59(6):929-30. doi: 10.1016/j.eururo.2011.03.014. Epub 2011 Mar 21. PubMed PMID: 21444146.

Capitanio U. Contemporary management of patients with T1a and T1b prostate cancer. Curr Opin Urol. 2011 May;21(3):252-6. doi: 10.1097/MOU.0b013e328344e4ad. Review. PubMed PMID: 21358335.

Capitanio U, Suardi N. Prostate cancer in 2010: GSU: misclassification or biological progression? Nat Rev Urol. 2011 Feb;8(2):65-6. doi: 10.1038/nrurol.2010.247. Review. PubMed PMID: 21304540.

Capitanio U, Briganti A, Suardi N, Gallina A, Salonia A, Freschi M, Rigatti P, Montorsi F. When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy? Int J Urol. 2011 Feb;18(2):148-53. doi: 10.1111/j.1442-2042.2010.02689.x. Epub 2010 Dec 30. PubMed
PMID: 21198944.

Capitanio U, Pellucchi F, Gallina A, Briganti A, Suardi N, Salonia A, Abdollah F, Di Trapani E, Jeldres C, Cestari A, Karakiewicz PI, Montorsi F. How can we predict lymphorrhoea and clinically significant lymphocoeles after radical prostatectomy and pelvic lymphadenectomy? Clinical implications. BJU Int. 2011 Apr;107(7):1095-101. doi: 10.1111/j.1464-410X.2010.09580.x. Epub 2010 Sep 29. PubMed PMID: 20880192.

Capitanio U, Briganti A, Gallina A, Suardi N, Karakiewicz PI, Montorsi F, Scattoni V. Predictive models before and after radical prostatectomy. Prostate. 2010 Sep 1;70(12):1371-8. doi: 10.1002/pros.21159. Review. PubMed PMID: 20623635.

Capitanio U, Isbarn H, Shariat SF, Jeldres C, Zini L, Saad F, Graefen M, Montorsi F, Perrotte P, Karakiewicz PI. Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology. 2009 Oct;74(4):858-64. doi: 10.1016/j.urology.2009.03.052. Epub 2009 Jul 22. PubMed PMID: 19628260.

Capitanio U, Jeldres C, Perrotte P, Isbarn H, Crépel M, Cloutier V, Baillargeon-Gagne S, Shariat SF, Duclos A, Arjane P, Widmer H, Saad F, Montorsi F, Karakiewicz PI. Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.  Urology. 2009 Aug;74(2):373-7. doi: 10.1016/j.urology.2009.01.085. Epub 2009 Jun 7. PubMed PMID: 19501893.

Capitanio U, Karakiewicz PI, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F. The probability of Gleason score upgrading between biopsy and radical prostatectomy can be accurately predicted. Int J Urol. 2009 May;16(5):526-9. doi: 10.1111/j.1442-2042.2009.02270.x. Epub 2009 Mar 26. PubMed PMID: 19389085.

Capitanio U, Perrotte P, Zini L, Jeldres C, Shariat SF, Isbarn H, Arjane P, Peloquin F, Pharand D, Montorsi F, Karakiewicz PI. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma). BJU Int. 2009 Sep;104(6):795-9. doi:10.1111/j.1464-410X.2009.08484.x. Epub 2009 Apr 15. PubMed PMID: 19389018.

Capitanio U, Perrotte P, Zini L, Suardi N, Antebi E, Cloutier V, Jeldres C, Shariat SF, Duclos A, Arjane P, Saad F, Montorsi F, Karakiewicz PI. Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort. Urology. 2009 Jun;73(6):1323-7. doi: 10.1016/j.urology.2008.10.026. Epub 2009 Apr 18. PubMed PMID: 19376563.

Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol. 2009 Jul;56(1):1-9. doi: 10.1016/j.eururo.2009.03.072. Epub 2009 Apr 3. PubMed PMID: 19361911.

Capitanio U, Karakiewicz PI, Valiquette L, Perrotte P, Jeldres C, Briganti A, Gallina A, Suardi N, Cestari A, Guazzoni G, Salonia A, Montorsi F. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer. Urology. 2009 May;73(5):1087-91. doi: 10.1016/j.urology.2008.10.048. Epub 2009 Feb 4. PubMed PMID: 19195695.

Capitanio U, Cloutier V, Zini L, Isbarn H, Jeldres C, Shariat SF, Perrotte P, Antebi E, Patard JJ, Montorsi F, Karakiewicz PI. A critical assessment of the  prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 2009 Jun;103(11):1496-500. doi: 10.1111/j.1464-410X.2008.08259.x. Epub 2008 Dec 8. PubMed PMID: 19076149.

Capitanio U, Suardi N, Shariat SF, Lotan Y, Palapattu GS, Bastian PJ, Gupta  A, Vazina A, Schoenberg M, Lerner SP, Sagalowsky AI, Karakiewicz PI. Assessing the minimum number of lymph nodes needed at radical cystectomy in patients with bladder cancer. BJU Int. 2009 May;103(10):1359-62. doi:10.1111/j.1464-410X.2008.08212.x. Epub 2008 Dec 8. PubMed PMID: 19076140.

Capitanio U, Perrotte P, Hutterer GC, Suardi N, Jeldres C, Shariat SF, Duclos A, Arjane P, Montorsi F, Karakiewicz PI. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men. Int J Urol. 2009 Jan;16(1):91-5. doi: 10.1111/j.1442-2042.2008.02192.x. Epub 2008 Nov 27. PubMed PMID: 19054167.

Capitanio U, Jeldres C, Patard JJ, Perrotte P, Zini L, de La Taille A, Ficarra V, Cindolo L, Bensalah K, Artibani W, Tostain J, Valeri A, Zigeuner R, Méjean A, Descotes JL, Lechevallier E, Mulders PF, Lang H, Jacqmin D, Karakiewicz PI. Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma. BJU Int. 2009 Jan;103(1):33-7. doi: 10.1111/j.1464-410X.2008.08014.x. Epub 2008 Oct 16. PubMed PMID: 18990161.

Capitanio U, Zini L, Perrotte P, Shariat SF, Jeldres C, Arjane P, Pharand D, Widmer H, Péloquin F, Montorsi F, Patard JJ, Karakiewicz PI. Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study. Urology. 2008 Nov;72(5):1090-5. doi: 10.1016/j.urology.2008.06.059. Epub 2008 Sep 16. PubMed PMID: 18799207.

Capitanio U, Briganti A, Shariat SF, Karakiewicz PI. The importance of the quantification of the extent of cancer in prostatic biopsies in prediction of biochemical recurrence: a global perspective. Eur Urol. 2008 Oct;54(4):717-9. doi: 10.1016/j.eururo.2008.07.034. Epub 2008 Jul 21. PubMed PMID: 18703272.

Capitanio U, Ahyai S, Graefen M, Jeldres C, Shariat SF, Erbersdobler A, Schlomm T, Haese A, Steuber T, Heinzer H, Perrotte P, Péloquin F, Pharand D, Arjane P, Huland H, Karakiewicz PI. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. Urology.2008 Dec;72(6):1208-11; discussion 1212-3. doi: 10.1016/j.urology.2008.04.053. Epub 2008 Aug 9. PubMed PMID: 18692880.

Capitanio U, Karakiewicz PI, Jeldres C, Briganti A, Salonia A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. Suspected clinical T3 prostate cancer is associated with a high rate of negative extended biopsies: clinical implications. Eur Urol. 2009 Jan;55(1):253-4. doi: 10.1016/j.eururo.2008.05.025. Epub 2008 May  22. PubMed PMID: 18513849.

Capitanio U, Jeldres C, Shariat SF, Karakiewicz P. Clinicians are most familiar with nomograms and rate their clinical usefulness highest, look-up tables are second best. Eur Urol. 2008 Oct;54(4):958-9. doi: 10.1016/j.eururo.2008.04.082. Epub 2008 May 8. PubMed PMID: 18485579.

Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence. Eur Urol. 2008 Jul;54(1):118-25. doi: 10.1016/j.eururo.2008.02.018. Epub 2008 Feb 26. PubMed PMID: 18314255